Leqembi recommended for treatment of early Alzheimer’s disease

View source ↗

Summary

The EMA CHMP recommended Leqembi (lecanemab) for treatment of early Alzheimer's disease in a restricted patient population after a re-examination found that ben…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

Re-examination concludes that benefits outweigh risks in a restricted patient population